Alumis director Srinivas Akkaraju reports disposal of 96,131 common shares worth $1.01 million
ALMS•Insider transaction details
Director Srinivas Akkaraju reported net purchases of Alumis common stock through affiliated funds in early September 2026.
- On Sept. 4, Samsara BioCapital bought 220,070 shares at $11.17; Samsara Opportunity Fund bought 220,070 shares at $11.17.
- On Sept. 8, the funds sold 48,066 shares at $10.55, then bought 273,291 shares at $10.63.
- Post-transaction holdings: 4,937,026 shares at Samsara BioCapital; 2,298,783 shares at Samsara Opportunity Fund; 3,553 shares held directly.
